$2.81 Billion is the total value of Carlyle Group Inc.'s 27 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 57.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MKSI | Sell | MKS Instrs Inc | $376,483,329 | -49.9% | 3,482,732 | -58.9% | 13.41% | -40.2% |
Sell | Getty Images Holdings Inc | $48,684,344 | -19.6% | 9,976,300 | -16.2% | 1.73% | -4.0% | |
VERA | Sell | Vera Therapeutics Inccl a | $38,766,065 | +69.4% | 2,416,837 | -18.4% | 1.38% | +102.2% |
Exit | Sientra Inc | $0 | – | -167,358 | -100.0% | -0.01% | – | |
CBAY | Exit | Cymabay Therapeutics Inc | $0 | – | -131,036 | -100.0% | -0.03% | – |
LSI | Exit | Life Storage Inc | $0 | – | -86,000 | -100.0% | -0.34% | – |
PCVX | Exit | Vaxcyte Inc | $0 | – | -1,923,158 | -100.0% | -2.15% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-04
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Wesco Aircraft Hldgs Inc | 28 | Q4 2019 | 16.8% |
Seacor Marine Hldgs Inc | 22 | Q3 2023 | 1.1% |
Enviva Partners LP | 21 | Q2 2020 | 31.5% |
Enduro Rty Tr | 21 | Q1 2018 | 2.8% |
USA Compression Partners LP | 20 | Q2 2018 | 28.5% |
Pattern Energy Group Inc | 20 | Q3 2018 | 16.2% |
Concord Med Svcs Hldgs Ltd | 19 | Q3 2017 | 1.1% |
Superior Energy Svcs Inc | 19 | Q3 2017 | 0.7% |
Cobalt Intl Energy Inc | 17 | Q1 2017 | 11.0% |
Sequential Brnds Group Inc N | 17 | Q1 2020 | 1.7% |
View Carlyle Group Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Complete Solaria, Inc. | September 22, 2023 | 2,745,879 | 5.7% |
Carlyle Credit Income Fund | September 14, 2023 | 4,785,628 | 41.0% |
Vera Therapeutics, Inc. | August 02, 2023 | 1,872,764 | 4.2% |
Reneo Pharmaceuticals, Inc. | May 09, 2023 | 2,730,457 | 8.2% |
EXICURE, INC. | April 13, 2023 | 287,137 | 3.4% |
SPRUCE BIOSCIENCES, INC. | February 23, 2023 | 3,734,518 | 9.2% |
Vaxcyte, Inc. | February 10, 2023 | 2,070,724 | 2.6% |
NuCana plc | August 11, 2022 | 3,353,134 | 6.4% |
1Life Healthcare Inc | February 11, 2022 | 13,612,681 | 7.1% |
Atotech Ltd | February 11, 2022 | 153,672,703 | 78.9% |
View Carlyle Group Inc.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-05-23 |
4 | 2024-05-23 |
4 | 2024-05-23 |
4 | 2024-05-23 |
4 | 2024-05-23 |
SC 13D/A | 2024-05-14 |
SC 13D/A | 2024-05-13 |
10-Q | 2024-05-07 |
13F-HR | 2024-05-03 |
4 | 2024-05-03 |
View Carlyle Group Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.